PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsIodopovidone
Iodopovidone
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
526 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_0000544—138192555
Surgical wound infectionD013530———510162655
Communicable diseasesD003141——12681128
Postoperative painD010149—G89.18———22426
Covid-19D000086382—U07.15816523
Wound infectionD014946———284821
Wounds and injuriesD014947—T14.8——331016
Macular edemaD008269——1—42512
PainD010146EFO_0003843R52——12912
Macular degenerationD008268EFO_0001365H35.301——2710
Show 86 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dental cariesD003731EFO_0003819K02152—19
AgnosiaD000377EFO_0007136F88—12—58
Postoperative complicationsD011183———13—48
UlcerD014456MPATH_579——11—57
InfertilityD007246EFO_0000545———1—56
Wound healingD014945GO_0042060———1—56
Retinal diseasesD012164—H35.9—13—15
SepsisD018805EFO_0001420A41.9——1—45
Obstetric labor complicationsD007744————2—24
Pain managementD059408————2—24
Show 45 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetes mellitusD003920EFO_0000400E08-E13—1——23
Prostatic neoplasmsD011471—C61—1——23
Retinitis pigmentosaD012174—H35.5222———3
RetinitisD012173—H30.922———3
NeuralgiaD009437EFO_0009430——1——12
Back painD001416—M54—1——12
Acne vulgarisD000152EFO_0003894L70—1——12
PneumothoraxD011030—J93.1111——12
Spinal cord injuriesD013119EFO_1001919——1———1
Type 2 diabetes mellitusD003924EFO_0001360E11—1———1
Show 11 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dry eye syndromesD015352—H04.121———23
MyopiaD009216EFO_0003927H52.11———23
EdemaD004487—R60.91———23
RhinosinusitisD000096825——1———12
DiseaseD004194EFO_0000408R691———12
OtomycosisD059249——1———12
SinusitisD012852EFO_0007486J321————1
Ingrown nailsD009263—L60.01————1
RhinoplastyD012225——1————1
Diabetic angiopathiesD003925EFO_1000896—1————1
Show 2 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AnalgesiaD000698——————66
Pilonidal sinusD010864—L05————66
CataractD002386EFO_0001059H26.9————55
Intervertebral disc displacementD007405EFO_1001800—————55
Cesarean sectionD002585——————44
ContraceptionD003267——————44
FistulaD005402——————44
Hip osteoarthritisD015207EFO_1000786M16————44
Shoulder painD020069—M25.51————44
Temporomandibular joint disordersD013705—M26.6————44
Show 166 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use